Biocon Q3 FY10 Results : Net up 173.26%

by khalid on 22/01/2010 · 0 comments

Biocon Ltd. is involve into manufacture biotechnological products through fermentation based technology. The company is a fully integrated health care company that delivers innovative biopharma solutions. The company has posted a net profit for the period Q3 (ending Dec 09) of the current fiscal (FY10). During the said quarter, net profit rose 173.26% to Rs 65.80 crores in comparison to the Rs 24.08 crores profit of Q3 (ending Dec 08) of previous year(FY09).

The company informed the market(BSE) that the net sales increased 36.82% to Rs 300.83 crores in Q3 FY10 when compared with the same quarter Q3 FY09 of previous year. Net sales was Rs 219.87 crores in last year’s quarter.

Share’s Data :
BSE Code : 532523
Mkt. Cap: Rs 5618 Crores
P/E Ratio: 50.40
EPS (Rs): 5.59
Face Value : Rs 5
Last Dividend : 60% in Apr 2009
52 Week H/L : Rs 304.50 / 90.10
Biocon Ltd. share’s CMP is Rs 280.90 on 22nd Jan 2010.

Reblog this post [with Zemanta]
Related Posts Plugin for WordPress, Blogger...

Leave a Comment

Previous post:

Next post: